GET THE APP

Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

+44 1223 790975

Lung Cancer Immunotherapy

Lung Cancer Immunotherapy is broadly divided into four main categories which includes Checkpoint inhibitors, Therapeutic vaccines, Monoclonal antibodies and T cell transfer. Checkpoint Inhibitors serve as checks and balances in the regulation of immune responses.

Therapeutic vaccines target tumor or shared -specific antigens. Monoclonal antibodies (mAbs) are molecules target specific antigens on tumors. In T cell transfer activity of T- cells is enhanced by modification or treatment with chemicals. They are modified with goal to improve immune system response against cancer.

Related Journals of Lung Cancer Immunotherapy

Immunotherapy: Open Access, Immunology Journal, Immunobiology journal, Immunome Research journal, Immunooncology journal, ATS Journals, Journal of Thoracic Disease, Clinical Medicine and Research, Frontiers in Oncology, Future Oncology.

High Impact List of Articles
Conference Proceedings
Top